U.S. Office REITs Stock News

In late February 2026, Northwest Natural Holding reported higher fourth-quarter and full-year 2025 results, with Q4 net income rising to US$57.79 million on sales of US$394.16 million and full-year net income reaching US$113.32 million on sales of US$1.29 billion, while initiating 2026 EPS guidance of US$2.95–US$3.15 and filing a US$57.81 million ESOP-related common stock shelf registration. Management also unveiled the long-term MX3 gas storage expansion project and reaffirmed 2026–2030 EPS...

Hecla Mining (HL) is back in focus after fresh news from its Greens Creek mine tailings project and recently released 2025 earnings, along with new 2026 production guidance and board level changes. See our latest analysis for Hecla Mining. The recent Greens Creek tailings progress, strong 2025 earnings update and fresh 2026 production guidance have coincided with a 9.37% 1 month share price return and a 385.91% 1 year total shareholder return. This suggests momentum has been building despite...

Turning Point Brands (TPB) has reported third quarter FY 2025 revenue of US$119 million and basic EPS of US$1.16, with trailing twelve month revenue at US$436 million and basic EPS of US$3.31. The company has seen quarterly revenue move from US$90.7 million in the third quarter of 2024 to US$119 million in the third quarter of 2025, while quarterly basic EPS went from US$0.71 to US$1.16 over the same span. This sets up a story where higher recent earnings meet a shift in net profit margins...

NuScale Power (SMR) has drawn investor attention after recent trading left the stock with a return of about 3.6% over the past week, while showing double digit declines over the month and the past 3 months. See our latest analysis for NuScale Power. Zooming out, NuScale Power’s recent 3.6% 7 day share price return sits against a 1 month share price decline of about 25% and a year to date share price fall of roughly 20%. Its 3 year total shareholder return is about 28%, which hints that recent...

In February 2026, AMD and Nutanix announced a multi-year partnership to build an open, full-stack AI infrastructure platform for agentic AI, alongside AMD’s planned US$150,000,000 equity investment in Nutanix at US$36.26 per share and up to US$100,000,000 in joint engineering and go-to-market funding. The deal effectively ties Nutanix’s hybrid cloud software to AMD’s EPYC CPUs, Instinct GPUs, and ROCm ecosystem, positioning the two companies to offer enterprises an alternative to vertically...

Kingsoft Cloud Holdings (NasdaqGS:KC) recently raised the annual caps on related-party property services and lease transactions with Kingsoft Corporation for 2026 and 2027, prompting a roughly 6% share price drop as investors assessed higher fixed cost exposure. See our latest analysis for Kingsoft Cloud Holdings. The latest announcement comes after a period of mixed performance, with a 17.3% year to date share price return but a 14.3% decline in 1 year total shareholder return, while the 3...

Compugen (CGEN) has just reported its FY 2025 results, with Q3 revenue of US$1.9 million and a basic EPS loss of US$0.07. Trailing twelve month figures show revenue of US$6.9 million and a basic EPS loss of US$0.30. The company has seen quarterly revenue range from US$1.3 million to US$2.3 million in FY 2025 so far, with basic EPS losses between US$0.07 and US$0.08 over the same stretch. This sets up a picture in which top line consistency still sits alongside negative earnings. With revenue...

If you are wondering whether Realty Income is fairly priced at its current level, this article explains how its market value compares with several valuation checks. With the share price at US$67.56 and returns of 1.3% over 7 days, 10.5% over 30 days, 17.9% year to date, 24.1% over 1 year, 24.1% over 3 years and 48.6% over 5 years, many investors are reassessing what they are willing to pay for the stock. Recent attention on Realty Income has centered on its role as a large US REIT for...

Enterprise Products Partners (EPD) is back in focus after quarterly results that exceeded revenue and EBITDA expectations. The company also announced new infrastructure projects and received positive analyst commentary tied to its long distribution track record and disciplined balance sheet. See our latest analysis for Enterprise Products Partners. The latest quarterly beat and a full pipeline of growth projects have coincided with a solid 11.15% 1 month share price return and a 15.32% 3...

Why PYRUKYND’s UAE approval is drawing fresh attention to Agios Pharmaceuticals The recent approval of PYRUKYND (mitapivat) in the United Arab Emirates for certain thalassemia patients gives Agios Pharmaceuticals (AGIO) a new commercial foothold in the Gulf region and a fresh catalyst for investor interest. See our latest analysis for Agios Pharmaceuticals. Investors have been reacting to a mix of clinical milestones and events such as Agios’ upcoming presentation at the TD Cowen Health Care...

Red Rock Resorts (RRR) has drawn attention after recent share performance, with a 1 day return of negative 3.15% and mixed moves over the past week, month and past 3 months. See our latest analysis for Red Rock Resorts. That 1 day share price decline and softer 30 day share price return sit alongside a 2.26% 3 month share price gain and a much stronger 1 year total shareholder return of 30.46%. This suggests that longer term momentum has been more positive than the very recent trading...

Why Northrop Grumman stock is on investors’ radar Northrop Grumman (NOC) has drawn attention recently as investors weigh its current valuation against its track record of revenue and net income growth, along with strong multi year total returns. See our latest analysis for Northrop Grumman. At a share price of US$724.38, Northrop Grumman has recently seen a 1 day share price return of 1.9% and a 30 day share price return of 4.6%. Its 1 year total shareholder return of 55.5% and 5 year total...

What Hinge Health’s latest trading move signals for investors Hinge Health (HNGE) has caught investor attention after a recent move in its share price, with the stock closing at US$42.76 as short term returns and fundamentals offer a mixed picture. See our latest analysis for Hinge Health. The recent 7 day share price return of 11.21% and 30 day share price return of 22.52% sit against a weaker 90 day share price return of 8.16% and year to date share price return of 6.15%. This suggests...

Ascendis Pharma (NasdaqGS:ASND) is in focus after the U.S. FDA granted accelerated approval for YUVIWEL, a once weekly treatment for children with achondroplasia, along with a Rare Pediatric Disease Priority Review Voucher. See our latest analysis for Ascendis Pharma. The FDA approval, Rare Pediatric Disease Priority Review Voucher and upcoming conference appearance at the TD Cowen Health Care Conference come alongside a 1 year total shareholder return of 59.34% and a 3 month share price...

Kaspi.kz has reported past fourth-quarter 2025 results, with revenue of KZT 1,145,548 million up from KZT 730,351 million a year earlier, while net income eased to KZT 276,983 million from KZT 316,401 million. Alongside this, the company is pushing new payment technology such as its Kaspi Alakan ‘Pay by Palm’ biometric system and reiterating its focus on value-added services and the Hepsiburada integration. We’ll now examine how Kaspi.kz’s strong revenue growth alongside its Kaspi Alakan...

The Cheesecake Factory reported past fourth-quarter 2025 sales of US$961.56 million versus US$920.96 million a year earlier, while net income fell to US$28.78 million from US$41.15 million, and full-year 2025 sales rose to US$3.75 billion as net income eased to US$148.43 million from US$156.78 million. Alongside these mixed results, the company raised its quarterly cash dividend to US$0.30 per share and continued repurchasing stock, indicating an ongoing commitment to returning capital to...

In late February 2026, Strategic Education, Inc. reported fourth-quarter 2025 results showing revenue of US$323.21 million and net income of US$37.91 million, alongside a quarterly dividend of US$0.60 per share and completion of a long-running share repurchase authorization. The company’s earnings per share rose meaningfully year on year and were aided by AI-enabled productivity gains and strong growth in its higher-margin Education Technology Services segment, which together improved...

RLJ Lodging Trust (RLJ) shares are in focus after the company posted above-consensus fourth quarter results, highlighting stronger urban hotel performance, higher non-room revenue, active property conversions, and increased balance sheet flexibility from recent refinancing. See our latest analysis for RLJ Lodging Trust. At a share price of US$8.02, RLJ Lodging Trust has seen short term momentum pick up, with a 30 day share price return of 7.94% and a 90 day gain of 8.23%. This comes even...

In recent days, ZoomInfo Technologies reported that its upmarket customers now account for 74% of its business, Copilot AI has reached 20% of annual contract value, and the company approved an additional US$1.00 billion for share repurchases while providing cautious 2026 revenue guidance. At the same time, supportive comments from Nvidia CEO Jensen Huang about AI complementing enterprise software reframed how investors view ZoomInfo’s AI-focused evolution. We’ll now examine how Nvidia’s...

DoubleVerify Holdings (DV) has drawn fresh attention after unveiling a record US$300 million share repurchase program, even as its latest results showed softer revenue and earnings alongside moderate guidance for 2026. See our latest analysis for DoubleVerify Holdings. The buyback news arrived after a weak stretch, with the share price return down around 3% year to date and the 1 year total shareholder return down about 29%. However, the stock has bounced sharply in the last week as investors...

Option Care Health (OPCH) shares came into focus after the company reported fourth quarter and full year 2025 results, combining higher sales with margin pressure from biosimilar adoption, reaffirmed guidance and a larger share repurchase program. See our latest analysis for Option Care Health. At a share price of US$32.46, Option Care Health has seen pressure recently, with a 7 day share price return of a 10.06% decline and a 1 month share price return of a 4.53% decline. This is in contrast...

ESAB Corporation recently reported fourth-quarter 2025 results showing higher sales but lower earnings year-on-year, while its Board affirmed a quarterly cash dividend of US$0.10 per share payable on April 17, 2026. Alongside this, increased institutional ownership and the launch of the Ruffian EMP 270G welding generator signal growing interest in ESAB’s product portfolio and income-return profile. With ESAB maintaining its dividend and enhancing its welding offering, we’ll now examine how...

AerCap Holdings recently reported record quarterly net income and earnings per share, announced a new US$1.00 billion share repurchase program, and raised its 2026 quarterly dividend following strong full-year results. These moves, alongside a sharp increase in earnings guidance and growing institutional interest, highlight management’s confidence in AerCap’s cash generation and its emphasis on returning capital to shareholders. With AerCap’s sharply higher EPS guidance and larger dividend...

Visteon (VC) just packed several updates into its latest report, combining softer 2025 earnings, fresh 2026 sales guidance of US$3.625b to US$3.825b, a higher dividend, and a completed share repurchase program. See our latest analysis for Visteon. The latest report came with a sharp 3.1% one day share price decline and the stock now trades at US$95.67. However, a 14.3% one year total shareholder return contrasts with weaker three and five year total returns, hinting at recovering but...